Prospective Clinical Implementation of Paige Prostate Detect Artificial Intelligence Assistance in the Detection of Prostate Cancer in Prostate Biopsies: CONFIDENT P Trial Implementation of Artificial Intelligence Assistance in Prostate Cancer Detection.
Journal:
JCO clinical cancer informatics
PMID:
40036728
Abstract
PURPOSE: Pathologists diagnose prostate cancer (PCa) on hematoxylin and eosin (HE)-stained sections of prostate needle biopsies (PBx). Some laboratories use costly immunohistochemistry (IHC) for all cases to optimize workflow, often exceeding reimbursement for the full specimen. Despite the rise in digital pathology and artificial intelligence (AI) algorithms, clinical implementation studies are scarce. This prospective clinical trial evaluated whether an AI-assisted workflow for detecting PCa in PBx reduces IHC use while maintaining diagnostic safety standards.